Pulse Biosciences, Inc. (PLSE) Operating Margin
- Operating margin · 12 months: Value -7007.76%; Formula and calculation Operating income / revenue. Period ending 2026-06-30..
Operating margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | -7007.76% | Operating income / revenue. Period ending 2026-06-30. $-83.04M ÷ $1.19M × 100 ≈ -7007.76% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | -83.04M USD | Operating Income (Loss) |
| Revenue | 1.19M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | (m) | Cost of Goods and Services Sold |
| Research and development | 51.89M USD | Research and Development Expense |
| Selling, general and administration | 31.16M USD | Selling, General and Administrative Expense |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-06-30 | $-83.04M | $1.19M | (m) | $51.89M | $31.16M | -7007.76% |
| 2026-03-31 | $-78.05M | $751.00K | (m) | $47.00M | $30.89M | -10392.14% |
| 2025-12-31 | $-76.94M | $350.00K | (m) | $44.72M | $32.03M | -21982.57% |
| 2025-09-30 | $-78.95M | $86.00K | (m) | $44.46M | (m) | -91798.84% |
| 2025-06-30 | $-72.23M | $0.00 | (m) | $40.77M | (m) | (m) |
| 2025-03-31 | $-63.69M | $0.00 | (m) | $35.91M | (m) | (m) |
| 2024-12-31 | $-56.26M | $0.00 | (m) | $32.34M | (m) | (m) |
| 2024-09-30 | $-48.53M | $0.00 | (m) | $29.47M | (m) | (m) |
| 2024-06-30 | $-46.13M | $0.00 | (m) | $29.24M | (m) | (m) |
| 2024-03-31 | $-44.63M | $0.00 | (m) | $28.71M | (m) | (m) |
| 2023-12-31 | $-43.57M | $0.00 | (m) | $27.80M | (m) | (m) |
| 2023-09-30 | $-39.79M | $-9.00K | (m) | $24.09M | (m) | 442066.67% |
| 2023-06-30 | $-46.56M | $-9.00K | (m) | $21.14M | (m) | 517322.22% |
| 2023-03-31 | $-50.35M | $256.00K | (m) | $19.90M | (m) | -19666.41% |
| 2022-12-31 | $-58.06M | $700.00K | (m) | $20.84M | (m) | -8293.86% |
| 2022-09-30 | $-64.72M | $1.55M | (m) | $22.40M | (m) | -4167.55% |
| 2022-06-30 | $-60.97M | $2.13M | (m) | $24.34M | (m) | -2866.48% |
| 2022-03-31 | $-61.76M | (m) | (m) | $26.35M | (m) | (m) |
| 2021-12-31 | $-63.01M | $1.42M | $600.00K | $28.64M | (m) | -4443.86% |
| 2021-09-30 | $-61.25M | (m) | (m) | $30.41M | (m) | (m) |
| 2021-06-30 | (m) | (m) | (m) | $30.91M | (m) | (m) |
| 2021-03-31 | (m) | (m) | (m) | $29.33M | (m) | (m) |
| 2020-12-31 | $-49.85M | (m) | $500.00K | $26.44M | (m) | (m) |
| 2020-09-30 | (m) | (m) | (m) | $25.61M | (m) | (m) |
| 2019-12-31 | $-46.97M | (m) | $600.00K | $24.96M | (m) | (m) |
| 2019-09-30 | $-42.14M | (m) | (m) | $23.45M | (m) | (m) |
| 2019-06-30 | $-41.15M | (m) | (m) | $22.30M | (m) | (m) |
| 2019-03-31 | $-38.95M | (m) | (m) | $19.92M | (m) | (m) |
| 2018-12-31 | $-37.55M | (m) | $600.00K | $17.25M | (m) | (m) |
| 2018-09-30 | $-37.30M | (m) | (m) | $15.04M | (m) | (m) |
| 2018-06-30 | $-34.02M | (m) | (m) | $12.93M | (m) | (m) |
| 2018-03-31 | $-31.04M | (m) | (m) | $11.09M | (m) | (m) |
| 2017-12-31 | $-25.57M | (m) | (m) | $9.65M | (m) | (m) |
| 2017-09-30 | $-19.67M | (m) | (m) | $8.66M | (m) | (m) |
| 2017-06-30 | $-14.95M | (m) | (m) | $7.20M | (m) | (m) |
| 2017-03-31 | $-11.03M | (m) | (m) | $6.85M | (m) | (m) |
| 2016-12-31 | $-9.52M | (m) | (m) | $5.99M | (m) | (m) |
| 2016-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-12-31 | $-4.47M | (m) | (m) | $2.58M | (m) | (m) |
| 2015-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-12-31 | (m) | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 |